John W. Ellingboe

2.7k citations

54 papers · 1.8k indexed · h-index 25

Impact in

Organic Chemistry top 2%
- Synthesis and biological activity
- Catalytic C–H Functionalization Methods
- Asymmetric Synthesis and Catalysis
- Synthesis and Biological Evaluation
Hepatology top 10%
- Hepatitis C virus research

Papers in

Organic Chemistry 25
- Synthesis and biological activity 7
- Synthesis and Characterization of Heterocyclic Compounds 6
- Asymmetric Synthesis and Catalysis 4
Hepatology 6
- Hepatitis C virus research 6

Co-authors: Derek C. Cole Satoru Masamune Ariamala Gopalsamy Michael D. Collini Tarek S. Mansour Arie Zask William Choy Deborah L. Smith
Journals: Journal of Medicinal Chemistry (20 papers)Bioorganic & Medicinal Chemistry Letters (18 papers)Tetrahedron Letters (4 papers)Bioorganic & Medicinal Chemistry (2 papers)Journal of the American Chemical Society (1 paper)
Partner nations: United States Canada

In The Last Decade

John W. Ellingboe

53 papers receiving 1.7k citations

Peers

Countries citing papers authored by John W. Ellingboe

Since Specialization

Citations

This map shows the geographic impact of John W. Ellingboe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John W. Ellingboe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John W. Ellingboe more than expected).

Fields of papers citing papers by John W. Ellingboe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John W. Ellingboe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John W. Ellingboe. The network helps show where John W. Ellingboe may publish in the future.

Co-authors

The 25 scholars most cited alongside John W. Ellingboe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John W. Ellingboe Line = papers co-authored together John W. Ellingboe links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Design, synthesis, and evaluation of (2S,4R)-Ketoconazole sulfonamide analogs as potential treatments for Metabolic Syndrome Bioorganic & Medicinal Chemistry Letters ·Benjamin E. Blass, Pravin S. Iyer, Magid Abou‐Gharbia, Wayne E. Childers, John Gordon, C. X. Yu, George Morton, Premkumar Arumugam, Joshodeep Boruwa, John W. Ellingboe, Sayan Mitra, O. Sener Sahin, M S DIGE, Kazuhiko Kotani, Catherine L. Winder, Pratima Srivastava, R. Petrikova, Santiago Bari, O. A. Prykarpats'kyi	2016	10
2	Novel benzofuran derivatives with dual 5-HT1A receptor and serotonin transporter affinity Bioorganic & Medicinal Chemistry Letters ·Aranapakam M. Venkatesan, Osvaldo dos Santos, John W. Ellingboe, Deborah A. Evrard, Boyd L. Harrison, Deborah L. Smith, Rosemary Scerni, Geoffrey Hornby, Lee E. Schechter, Saltuk Buğra Kızılkaya	2010	26
3	Identification and Characterization of Acidic Mammalian Chitinase Inhibitors Journal of Medicinal Chemistry ·Derek C. Cole, Andrea Olland, Jaison Jacob, J.C. Brooks, Matthew G. Bursavich, Robert Czerwiński, 崔政伟, M. Catherine Johnson, Diane Joseph‐McCarthy, John W. Ellingboe, Laura Lin, Paweł Nowak, Romin A.V., James C. Strand, Amy Tam, Cara Williams, Shihua Yao, Désirée H.H. Tsao, Lori Fitz	2010	30
4	Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin Cancer Research ·Ker Yu, Lourdes Toral‐Barza, Celine Shi, Weiguo Zhang, Judy Lucas, Boris Shor, P. Kolle, Jeroen C. Verheijen, Kevin J. Curran, David J. Malwitz, Derek C. Cole, John W. Ellingboe, Semiramis Ayral‐Kaloustian, Tarek S. Mansour, James J. Gibbons, Robert T. Abraham, Paweł Nowak, Arie Zask	2009	277
5	Identification of a new class of small molecule C5a receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Jack J. Chen, Derek C. Cole, Moh Faisal Faris, 延明平田, John W. Ellingboe, Paweł Nowak, Gregory J. Tawa, Gabriel Berstein, Wei Li	2009	5
6	Novel imidazolopyrimidines as dual PI3-Kinase/mTOR inhibitors Bioorganic & Medicinal Chemistry Letters ·Aranapakam M. Venkatesan, Christoph M. Dehnhardt, Zecheng Chen, Efren Delos Santos, Osvaldo dos Santos, Matthew G. Bursavich, A. Gilbert, John W. Ellingboe, Semiramis Ayral‐Kaloustian, Gulnaz Khafizova, Natasja Brooijmans, Robert Mallon, Irwin Hollander, Larry Feldberg, Judy Lucas, Ker Yu, Jay Gibbons, Robert T. Abraham, Tarek S. Mansour	2009	23
7	1,2,4-Oxadiazolidin-3,5-diones and 1,3,5-triazin-2,4,6-triones as cytosolic phospholipase A2α inhibitors Bioorganic & Medicinal Chemistry Letters ·Ariamala Gopalsamy, Hui Yang, John W. Ellingboe, John C. McKew, Steve Tam, Diane Joseph‐McCarthy, Wen Zhang, Marina W. H. Shen, James D. Clark	2006	16
8	Design and synthesis of 2,3,4,9-tetrahydro-1H-carbazole and 1,2,3,4-tetrahydro-cyclopenta[b]indole derivatives as non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA polymerase Bioorganic & Medicinal Chemistry Letters ·Ariamala Gopalsamy, Mengxiao Shi, Boris Dumenĉić, Kaapjoo Park, John W. Ellingboe, Mark Orlowski, Boris Feld, Anita Y. M. Howe	2006	15
9	Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Derek C. Cole, Danica May, Joseph R. Stock, John W. Ellingboe, Hossein Mazandarani, Deborah L. Smith, Guoming Zhang, Gregory J. Tawa, Lee E. Schechter	2005	28
10	Pyrazolo[1,5-a]pyrimidin-7-yl phenyl amides as novel anti-proliferative agents: parallel synthesis for lead optimization of amide region Bioorganic & Medicinal Chemistry Letters ·Ariamala Gopalsamy, Hui Yang, John W. Ellingboe, Hwei‐Ru Tsou, Nan Zhang, Pallasco Yugsi, Dennis Powell, Miriam Miranda, John P. McGinnis, Sridhar K. Rabindran	2005	56
11	Identification of [(naphthalene-1-carbonyl)-amino]-acetic acid derivatives as nonnucleoside inhibitors of HCV NS5B RNA dependent RNA polymerase Bioorganic & Medicinal Chemistry Letters ·Ariamala Gopalsamy, Robert D. Lambourne, John W. Ellingboe, Girija Krishnamurthy, Mark Orlowski, Boris Feld, Marja van Zeijl, Anita Y. M. Howe	2004	9
12	N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Derek C. Cole, John W. Ellingboe, Danica May, Hossein Mazandarani, Deborah L. Smith, Joseph R. Stock, Guoming Zhang, Ping Zhou, Lee E. Schechter	2004	37
13	Use of Design of Experiments To Optimize High-Throughput Semipreparative LC and LC/MS Methods Journal of Combinatorial Chemistry ·Derek C. Cole, N. J. Pagano, 侯莉敏, John W. Ellingboe	2003	15
14	New oxadiazolidinedione derivatives as potent and selective human β3 agonists Bioorganic & Medicinal Chemistry Letters ·Baihua Hu, Michael S. Malamas, John W. Ellingboe, Elwood Largis, Stella Han, 张晓涛, Masatsune Kainosho	2001	18
15	2,4-thiazolidinediones as potent and selective human β3 agonists Bioorganic & Medicinal Chemistry Letters ·Baihua Hu, John W. Ellingboe, Iwan Gunawan, Stella Han, Elwood Largis, Zenan Li, Michael S. Malamas, 张晓涛, Rachel McCord, Fuk‐Wah Sum, Masatsune Kainosho, H. A. Lurie	2001	31
16	Parallel solid-phase synthesis of vitronectin receptor (αvβ3) inhibitors Bioorganic & Medicinal Chemistry Letters ·Ariamala Gopalsamy, Hui Yang, John W. Ellingboe, Kenneth L. Kees, B J Araujo, Richard J. Murrills	2000	7
17	Prodrugs of CL316243: a selective β3-adrenergic receptor agonist for treating obesity and diabetes Bioorganic & Medicinal Chemistry Letters ·Yu. T. Trubnikov, A. Gilbert, Aradhana M. Venkatesan, Patricia Zárate Castañón, H. A. Lurie, Mohamad Izham Che Ros, Gerardo D. Francisco, Charache, G Grosu, Jillian G. Baker, John W. Ellingboe, Michael S. Malamas, Iwan Gunawan, 農林省林業試験場木材部, Elwood Largis, K. Steiner	1999	19
18	Antihyperglycemic activity of novel naphthalenylmethyl-3H-1,2,3,5-oxathiadiazole 2-oxides Journal of Medicinal Chemistry ·John W. Ellingboe, Louis J. Lombardo, Thomas R. Alessi, Thomas T. Nguyen, Lara Silveira Ivo, Charles J. Guinosso, 守雄河村, 谷口あき, Jehan F. Bagli	1993	17
19	Antihyperglycemic activity of novel substituted 3H-1,2,3,5-oxathiadiazole 2-oxides Journal of Medicinal Chemistry ·John W. Ellingboe, Thomas R. Alessi, M BECK, Thomas T. Nguyen, Elizabeth Kay Swanson, Lara Silveira Ivo, Jehan F. Bagli, Michael L. McCaleb	1992	31
20	Class III antiarrhythmic activity of novel substituted 4-[(methylsulfonyl)amino]benzamides and sulfonamides Journal of Medicinal Chemistry ·John W. Ellingboe, Walter Spinelli, V P Sonalkar, Thomas T. Nguyen, 朋美堺谷, J O’Connor Patrick, Jan M. Kitzen, Chang-Hee Lee, Jehan F. Bagli	1992	49

About John W. Ellingboe

John W. Ellingboe is a scholar working on Organic Chemistry, Hepatology, Molecular Biology, Pharmacology and Animal Science and Zoology, having authored 54 papers that have together received 1.8k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (10 papers), Synthesis and biological activity (7 papers), Chemical Synthesis and Analysis (7 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers), Hepatitis C virus research (6 papers), HIV/AIDS drug development and treatment (5 papers), Asymmetric Synthesis and Catalysis (4 papers) and Peptidase Inhibition and Analysis (4 papers). The work is most often cited by research in Organic Chemistry (906 citations), Hepatology (115 citations), Molecular Biology (893 citations), Computational Theory and Mathematics (137 citations) and Toxicology (29 citations). John W. Ellingboe has collaborated with scholars based in United States and Canada. Frequent co-authors include Derek C. Cole, Satoru Masamune, Ariamala Gopalsamy, Michael D. Collini, Tarek S. Mansour, Arie Zask, William Choy, Deborah L. Smith, Kevin J. Curran and Lee E. Schechter. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Bioorganic & Medicinal Chemistry and Journal of the American Chemical Society.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact